(VIANEWS) – Neurocrine Biosciences (NBIX), Agilysys (AGYS), NV5 Global (NVEE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Neurocrine Biosciences (NBIX)
24% sales growth and 4.16% return on equity
Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $0.62.
PE Ratio
Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 147.13. Meaning, the purchaser of the share is investing $147.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.16%.
2. Agilysys (AGYS)
18% sales growth and 10.51% return on equity
Agilysys, Inc., together with its subsidiaries, operates as a developer and marketer of hardware and software products and services to the hospitality industry in North America, Europe, the Asia-Pacific, and India. It offers point of sale, property management systems, payment, inventory and procurement, reservations and venue management, activity management, document management, and analytics and marketing loyalty solutions to enhance guest experience. The company also provides technical software support, maintenance, and subscription services; and professional services. It offers its solutions for gaming, hotels, resorts and cruise, corporate foodservice management, restaurants, universities, stadia, and healthcare. The company was formerly known as Pioneer-Standard Electronics, Inc. and changed its name to Agilysys, Inc. in 2003. Agilysys, Inc. was founded in 1963 and is headquartered in Alpharetta, Georgia.
Earnings Per Share
As for profitability, Agilysys has a trailing twelve months EPS of $0.42.
PE Ratio
Agilysys has a trailing twelve months price to earnings ratio of 166.02. Meaning, the purchaser of the share is investing $166.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.51%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 33.3% and a negative 16.7%, respectively.
Yearly Top and Bottom Value
Agilysys’s stock is valued at $69.73 at 16:22 EST, way under its 52-week high of $88.16 and way higher than its 52-week low of $35.85.
3. NV5 Global (NVEE)
17.5% sales growth and 6.96% return on equity
NV5 Global, Inc. provides professional and technical engineering and consulting services to public and private sector clients in the infrastructure, utility services, construction, real estate, and environmental markets in the United States and internationally. It operates through three segments: Infrastructure; Building, Technology & Sciences; and Geospatial Solutions. The company offers site selection and planning, design, water resources, transportation, structural engineering, land development, surveying, power delivery, building code compliance, and other services; and construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting services. It also provides governmental outsourcing and consulting, and technical outsourcing services; and geospatial data analytic and mapping services. In addition, the company offers mechanical, electrical, and plumbing design; commissioning; energy performance, management, and optimization; building program management; acoustical design consulting; and audiovisual–security and surveillance–information technology–data center services, as well as energy services. Further, it provides various services, such as investigating and analyzing environmental conditions, and recommending corrective measures and procedures; occupational health and safety services; radiation exposure and protection, and nuclear safety and industrial hygiene analyses services; hydrogeological modeling and environmental programs; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; permitting and compliance; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was formerly known as NV5 Holdings, Inc. and changed its name to NV5 Global, Inc. in December 2015. NV5 Global, Inc. was founded in 1949 and is headquartered in Hollywood, Florida.
Earnings Per Share
As for profitability, NV5 Global has a trailing twelve months EPS of $3.11.
PE Ratio
NV5 Global has a trailing twelve months price to earnings ratio of 30.34. Meaning, the purchaser of the share is investing $30.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.96%.
Sales Growth
NV5 Global’s sales growth is 9.5% for the present quarter and 17.5% for the next.
4. Owens (OI)
7% sales growth and 47.84% return on equity
O-I Glass, Inc., through its subsidiaries, manufactures and sells glass containers to food and beverage manufacturers primarily in the Americas, Europe, and the Asia Pacific. It produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. The company is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. It offers glass containers in a range of sizes, shapes, and colors. The company sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. O-I Glass, Inc. was founded in 1903 and is headquartered in Perrysburg, Ohio.
Earnings Per Share
As for profitability, Owens has a trailing twelve months EPS of $4.42.
PE Ratio
Owens has a trailing twelve months price to earnings ratio of 4.95. Meaning, the purchaser of the share is investing $4.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.84%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Owens’s EBITDA is 1.03.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 13.7% and 1.6%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.2%, now sitting on 6.99B for the twelve trailing months.
Volume
Today’s last reported volume for Owens is 799660 which is 27.38% below its average volume of 1101180.
5. Extra Space Storage (EXR)
6.3% sales growth and 23.07% return on equity
Extra Space Storage Inc., headquartered in Salt Lake City, Utah, is a self-administered and self-managed REIT and a member of the S&P 500. As of December 31, 2022, the Company owned and/or operated 2,338 self-storage stores in 41 states and Washington, D.C. The Company's stores comprise approximately 1.6 million units and approximately 176.1 million square feet of rentable space. The Company offers customers a wide selection of conveniently located and secure storage units across the country, including boat storage, RV storage and business storage. The Company is the second largest owner and/or operator of self-storage stores in the United States and is the largest self-storage management company in the United States.
Earnings Per Share
As for profitability, Extra Space Storage has a trailing twelve months EPS of $6.36.
PE Ratio
Extra Space Storage has a trailing twelve months price to earnings ratio of 23.06. Meaning, the purchaser of the share is investing $23.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.07%.
